Insulin Pen Buyers Say Sanofi Antitrust Suit Not Overly Broad

Buyers of Sanofi-Aventis' Lantus insulin pen fought back Friday in Massachusetts federal court against the company's bid to trim their proposed antitrust class action on the grounds the buyer behind the...

Already a subscriber? Click here to view full article